Kemi Instrument has completed tens of millions of yuan in Series B financing, accelerating the domestic substitution of synthetic equipment and breakthroughs in continuous flow technology

Anhui Kemi Instrument Co., LtdAs a high-tech enterprise specializing in comprehensive solutions for synthetic equipment, we have recently completed a Series B financing of tens of millions of yuan. This round of financing is funded byChuangjing CapitalLeading investment,Changhai CapitalServe as a financial advisor.

This financing marks the recognition of Kemi Instrument's innovative strength and market potential in the field of synthetic equipment by the capital market. The funds will mainly be used for the company's scientific research instruments and equipment, small and medium-sized trial and industrial synthetic reaction equipment, continuous flow technology updates and iterations, and global business expansion.

In recent years, with policy support and technological breakthroughs, domestic instruments are accelerating their replacement. In the field of chemical reaction engineering, continuous flow reactor technology has become the key to industrial upgrading. Continuous flow reactors (such as tubular reactors) and batch reactors (such as stirred tanks) are suitable for different scenarios: Continuous flow reactors achieve large-scale production through stable operation, accurately control reaction conditions, and reduce side reactions; Intermittent reactors are known for their high flexibility and are suitable for small-scale, multi variety production.

At present, the global market size of continuous flow technology is about 1.7 billion US dollars, and it is expected to reach about 2.9 billion US dollars by 2028. It will continue to grow in the next few years, with a GAGR of about 15%. The growth rate of China's continuous flow technology market is higher than the global market, reaching about 25%. Continuous flow microreactors are efficient and precise chemical reaction systems widely used in fields such as pharmaceuticals, chemical engineering, and materials science. Currently, the continuous flow microreactor market is in a period of rapid growth, with pharmaceuticals and green chemistry being the core driving forces.

The pace of domestic substitution for continuous manufacturing is accelerating. Multiple departments including the Ministry of Industry and Information Technology, the National Health Commission, and the National Medical Products Administration have issued policies to accelerate technological innovation and application, promote green processes such as microchannels and continuous reactions, and break through a number of key core green technologies, providing policy guarantees for the healthy and high-quality development of the pharmaceutical industry. Domestic policies such as "Q13: Continuous Manufacturing of Active Pharmaceutical Ingredients and Preparations", "Guiding Principles for Continuous Manufacturing of Active Pharmaceutical Ingredients and Intermediates", "List of Petrochemical Green Processes", "Guiding Catalogue for Key Development of Frontier Materials Industrialization", etc. clearly support continuous flow processes. The promulgation of Q13 means that the method of continuous manufacturing of drugs has been officially included in the guidelines for international drug regulation, which will promote the widespread promotion and application of continuous manufacturing technology in the pharmaceutical industry.

01 Deeply cultivate the field of synthetic equipment and create a full category equipment platform

Kemi Instrument was founded in 2014 and is headquartered in Hefei Economic Development Zone. It is a high-tech enterprise specializing in the research and manufacturing of scientific research instruments, small and medium-sized experimental equipment, and industrial synthesis equipment. The company is based on mature experience in chemical reaction instruments, equipment, and processes, committed to achieving seamless integration from laboratory to industrialization, providing full process services from equipment to processes, and striving toBecoming an international standardA provider of reaction instruments and comprehensive synthesis solutions.

Relying on scientific research forces such as the University of Science and Technology of China, the company has formedResearch and development capability of intermittent and continuous flow full category synthetic equipmentOur products cover hydrothermal kettles, high-temperature furnace equipment (pyrolysis furnaces/CVD furnaces/rotary furnaces, etc.), fixed beds, photocatalytic reaction devices, etc., serving all 985 and 211 university laboratories and leading enterprises in strategic emerging industries such as new materials, new energy, and biomedicine in China.

Kemi Instrument has a research and development manufacturing base of nearly 10000 square meters and holds an A2 level Chinese special equipment (pressure vessel manufacturing) production qualification license. Our products are exported to Europe, America, Australia, the Middle East and other places, serving over 20000 domestic and foreign scientific research and enterprise customers, promoting the research and development of more than 4000 applications, and assisting users in publishing more than 1000 SCI (Zone 1) papers.

Kemi Instrument Product Matrix

02 Breakthrough continuous flow technology and promote industrial application upgrading

Kemi Instrument has established mature intermittent reaction system process capabilities, covering the entire category of equipment from "intermittent continuous flow". Its microchannel and fixed bed continuous flow technology have promoted the business from "small-scale" and "pilot" to "industrial scale", which is in line with the national green manufacturing strategy.

Kemi Instrument Continuous Flow Synthesis Reaction Device (Part)

A reactor is a core equipment in the production process of chemical, pharmaceutical, food and other fields. As a high-temperature and high-pressure sealed container, it provides a controlled environment for chemical reactions. In the medical field, reaction vessels are mainly used for drug synthesis and intermediate preparation, including synthesizing drugs, preparing drug intermediates, or optimizing related process conditions. They are important equipment in industries such as pharmaceuticals. By precisely controlling reaction conditions, they ensure that reactions proceed according to predetermined paths, directly affecting drug quality, production efficiency, and safety.

Kemi Instrument recently launched a new product - AI Robot ReactorThrough the self-developed module of the robotic arm full stack, the full process automation of high-pressure reactor experiments, including automatic lid closing, inflation, temperature control reaction, cooling and deflation, and lid opening, is achieved, greatly reducing the risk of manual operation. At the same time, the equipment is equipped with an AI intelligent online system (supporting ChatGPT/DeepSeek docking), and is equipped with a four-dimensional monitoring system for temperature/pressure/leakage. Real time warning and automatic shutdown functions ensure the safety of experiments, making dangerous experiments intelligent and pushing scientific research efficiency to the limit.

03 Continuously cultivating the upstream of synthetic reactions and expanding the global market

In recent years, the company has actively expanded its customer base in various segmented fields, developing new chemical synthesis equipment and solutions represented by continuous flow. Its industrial business has grown rapidly, with customers covering multiple strategic emerging industries such as biomedicine, new materials, new energy, and ecological environment. It is expected to continue to experience high-speed growth in the future.

For obtaining this round of financing,Founder of Kemi Instrument, Xu QingExpression: Thank you to the new and old shareholders for their support of Kemi's current round of financing, and thank you to Chuangjing Capital for recognizing the company and Changhai Capital for their professional services! Kemi Instrument adheres to the spirit of "rigorous professionalism, innovative efficiency, excellence, and value creation", and is committed to promoting the development of industrialization with professionalism and quality, providing more "safe, convenient, accurate, and efficient" instruments and equipment for scientific researchers to accelerate the achievement of scientific research results. After this round of financing, Kemi will rely on its existing research and development system and shareholder resources to further expand its equipment and technology solutions in areas such as continuous flow and photocatalysis. I hope to walk together with all my partners, grow together, and create a better future!

Thank you to the new and old shareholders for their support of Kemi's current round of financing, and thank you to Chuangjing Capital for recognizing the company and Changhai Capital for their professional services! Kemi Instrument adheres to the spirit of "rigorous professionalism, innovative efficiency, excellence, and value creation", and is committed to promoting the development of industrialization with professionalism and quality, providing more "safe, convenient, accurate, and efficient" instruments and equipment for scientific researchers to accelerate the achievement of scientific research results. After this round of financing, Kemi will rely on its existing research and development system and shareholder resources to further expand its equipment and technology solutions in areas such as continuous flow and photocatalysis. I hope to walk together with all my partners, grow together, and create a better future!